These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24104560)

  • 1. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
    Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
    Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
    Iwamoto T; Terai S; Hisanaga T; Takami T; Yamamoto N; Watanabe S; Sakaida I
    Cell Tissue Res; 2013 Mar; 351(3):487-95. PubMed ID: 23183782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
    Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
    Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
    Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis.
    Huang CK; Lee SO; Lai KP; Ma WL; Lin TH; Tsai MY; Luo J; Chang C
    Hepatology; 2013 Apr; 57(4):1550-63. PubMed ID: 23150236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
    Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
    Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver.
    Fujimiya T; Liu J; Kojima H; Shirafuji S; Kimura H; Fujimiya M
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G451-60. PubMed ID: 19608736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis.
    Jang YO; Jun BG; Baik SK; Kim MY; Kwon SO
    Clin Mol Hepatol; 2015 Jun; 21(2):141-9. PubMed ID: 26157751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
    Terai S; Takami T; Yamamoto N; Fujisawa K; Ishikawa T; Urata Y; Tanimoto H; Iwamoto T; Mizunaga Y; Matsuda T; Oono T; Marumoto M; Burganova G; Fernando Quintanilha L; Hidaka I; Marumoto Y; Saeki I; Uchida K; Yamasaki T; Tani K; Taura Y; Fujii Y; Nishina H; Okita K; Sakaida I
    Tissue Eng Part B Rev; 2014 Jun; 20(3):206-10. PubMed ID: 24450831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapy in chronic liver disease.
    Takami T; Terai S; Sakaida I
    Curr Opin Gastroenterol; 2012 May; 28(3):203-8. PubMed ID: 22395569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
    Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
    Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
    Luo XY; Meng XJ; Cao DC; Wang W; Zhou K; Li L; Guo M; Wang P
    Stem Cell Res Ther; 2019 Jan; 10(1):16. PubMed ID: 30635047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
    Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
    Liu Y; Yang X; Jing Y; Zhang S; Zong C; Jiang J; Sun K; Li R; Gao L; Zhao X; Wu D; Shi Y; Han Z; Wei L
    Sci Rep; 2015 Dec; 5():17762. PubMed ID: 26643997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of bone-marrow-derived mesenchymal stem cells differentiated with growth-factor-free coculture method in liver-injured rats.
    Li TZ; Kim JH; Cho HH; Lee HS; Kim KS; Lee SW; Suh H
    Tissue Eng Part A; 2010 Aug; 16(8):2649-59. PubMed ID: 20367252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.
    Jang YO; Kim YJ; Baik SK; Kim MY; Eom YW; Cho MY; Park HJ; Park SY; Kim BR; Kim JW; Soo Kim H; Kwon SO; Choi EH; Kim YM
    Liver Int; 2014 Jan; 34(1):33-41. PubMed ID: 23782511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.